Details for New Drug Application (NDA): 208085
✉ Email this page to a colleague
The generic ingredient in XTRELUS is guaifenesin; hydrocodone bitartrate. There are twenty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the guaifenesin; hydrocodone bitartrate profile page.
Summary for 208085
Tradename: | XTRELUS |
Applicant: | Eci Pharms Llc |
Ingredient: | guaifenesin; hydrocodone bitartrate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 400MG;5MG | ||||
Approval Date: | Apr 25, 2018 | TE: | RLD: | Yes |
Complete Access Available with Subscription